New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
07:49 EDTICPTIntercept price target raised to $525 from $360 at Oppenheimer
Oppenheimer increased its price target on Intercept after updating its valuation estimate of the company's OCA drug after positive data for the drug was reported. The firm thinks the stock could rise further as investors focus on potentially positive upcoming fibrosis data. Oppenheimer keeps an Outperform rating on the shares.
News For ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
15:22 EDTICPTIntercept CEO says company 'very well-positioned' in terms of balance sheet
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use